CELL RECEPTOR DEVELOPS A NOVEL THERAPY FOR HIGH MEDICAL NEED:

                                                   CANCER AND AUTOIMMUNE DISEASES.

Cell Receptor is an emerging Kiel-based R&D company developing a novel cell biology approach to treating cancer and autoimmune diseases. Our research targets a central extracellular signalling mechanism required by all growing cells – a therapeutic bottleneck.

By specifically blocking the interaction between tumour cells and blood platelets, we prevent tumour growth, metastasis and chemoresistance. This well-tolerated approach reduces side effects and can prevent the failure of conventional cancer therapies in many cases – with the potential to usher in a new era in oncology.

See this article:  https://www.nature.com/articles/d43747-021-00133-8

and this:            https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-025-00742-w

#cellreceptor #cancer treatment #oncology        Member of                          promoted by BSFZ